PFFL
ETRACS 2xMonthly Pay Leveraged Preferred Stock Index ETN [PFFL] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
PFFL Stock Summary
In the News
PFFL Financial details
Company Rating
-
Market Cap
0
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.12
Dividend %
15.02%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-10%
SMA100
-10%
Inst Own
0%
Inst Trans
0%
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.19-12.99
52W High
-21.88%
52W Low
+4.17%
RSI
45
Rel Volume
0.3
Avg Volume
5.81K
Volume
1.72K
Perf Week
-2.19%
Perf Month
-4.2%
Perf Quarter
-10.71%
Perf Half Y
-3.65%
-
-
-
-
Beta
-
-
-
Volatility
0.13%, 0.15%
Prev Close
-0.37%
Price
9.375
Change
-0.48%
PFFL Financial Performance
PFFL Frequently Asked Questions
What is ETRACS 2xMonthly Pay Leveraged Preferred Stock Index ETN stock symbol ?
ETRACS 2xMonthly Pay Leveraged Preferred Stock Index ETN is a US stock and trading under the symbol PFFL
What is ETRACS 2xMonthly Pay Leveraged Preferred Stock Index ETN stock quote today ?
ETRACS 2xMonthly Pay Leveraged Preferred Stock Index ETN stock price is $9.375 today.
Is ETRACS 2xMonthly Pay Leveraged Preferred Stock Index ETN stock public?
Yes, ETRACS 2xMonthly Pay Leveraged Preferred Stock Index ETN is a publicly traded company.
Company Profile
- Volume Average 5.81K
- Headquarters US
- IPO Date 2018-09-26
The index is designed to track the price movements of an equally weighted portfolio of two exchange-traded funds (“ETFs”) that hold preferred securities of various issuers. The Securities are two times leveraged with respect to the index and, as a result, will benefit from two times any beneficial, but will be exposed to two times any adverse, compounded monthly performance of the index.
